Cargando…
Testing of Adenoviral Vector Gene Transfer Products: FDA Expectations
This chapter describes the agency requirements and guidelines for drug development of adenoviral-containing products. The Food and Drug Administration (FDA) assessment of safety and ultimately effectiveness of adenovirus containing products involves thorough evaluation of the information contained i...
Autores principales: | Bauer, Steven R., Pilaro, Anne M., Weiss, Karen D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7155433/ http://dx.doi.org/10.1016/B978-012199504-1/50022-5 |
Ejemplares similares
-
Retargeting Adenoviral Vectors to Improve Gene Transfer into Tumors
por: Hogg, Richard T., et al.
Publicado: (2010) -
Peptide Targeting of Adenoviral Vectors to Augment Tumor Gene Transfer
por: Ballard, Erin N., et al.
Publicado: (2012) -
Editorial: Adenoviral Infection and Immunity, and Adenoviral Vectors for Gene Therapy Applications
por: Zhang, Qiwei, et al.
Publicado: (2022) -
Adenoviral Vectors for Hemophilia Gene Therapy
por: Brunetti-Pierri, N, et al.
Publicado: (2013) -
Factors influencing adenoviral gene transfer
por: Huizinga, TWJ, et al.
Publicado: (2001)